Pharmaceuticals roundup 2025

It’s been a turbulent year for the pharmaceutical industry, with US political decisions having broad ramifications both at home and abroad. Donald Trump’s on-again off-again tariff announcements have made for a challenging market environment, and his desire for ‘Most Favored Nation’ pricing has left companies scrambling to do deals on price cuts in the US, and ramp up their US-based operations.